Literature DB >> 9527093

Predicting angiographic narrowing > or = 50% in diameter in each of the three major arteries by amounts of calcium detected by electron beam computed tomographic scanning in patients with chest pain.

H Yamamoto1, M Imazu, Y Hattori, F Tadehara, M Yamakido, T Nakanishi, K Ito.   

Abstract

The evaluation of calcium of the coronary arteries on a vessel-by-vessel basis by use of electron beam computed tomography was useful in obstructed coronary arteries. The absence of coronary calcification in any vessel was highly specific for the absence of an obstructive lesion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9527093     DOI: 10.1016/s0002-9149(97)01011-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Predictors for target lesion microcalcifications in patients with stable coronary artery disease: an optical coherence tomography study.

Authors:  Sebastian Reith; Andrea Milzi; Rosalia Dettori; Nikolaus Marx; Mathias Burgmaier
Journal:  Clin Res Cardiol       Date:  2018-04-13       Impact factor: 5.460

Review 2.  Update on using coronary calcium screening by computed tomography to measure risk for coronary heart disease.

Authors:  Brad H Thompson; William Stanford
Journal:  Int J Cardiovasc Imaging       Date:  2005-02       Impact factor: 2.357

Review 3.  Calcium Modification Therapies in Contemporary Percutaneous Coronary Intervention.

Authors:  Mohammad Zaidan; Mohammad Alkhalil; Khaldoon Alaswad
Journal:  Curr Cardiol Rev       Date:  2022

Review 4.  Current understanding of coronary artery calcification.

Authors:  Wei Liu; Yue Zhang; Cheuk-Man Yu; Qing-Wei Ji; Meng Cai; Ying-Xin Zhao; Yu-Jie Zhou
Journal:  J Geriatr Cardiol       Date:  2015-11       Impact factor: 3.327

5.  Serum free fatty acids are associated with severe coronary artery calcification, especially in diabetes: a retrospective study.

Authors:  Yangxun Xin; Junfeng Zhang; Yuqi Fan; Changqian Wang
Journal:  BMC Cardiovasc Disord       Date:  2021-07-15       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.